The LEC Rat pp 114-119 | Cite as

Inhibitory and Intensifying Effects of Long-Term Exposure to Chemicals on Spontaneous Hepatic Injury in LEC Rats

  • Keisuke Izumi
  • Hisanori Uehara
  • Hisashi Otsuka
  • Kozo Matsumoto


Liver disease, including the so-called hereditary hepatitis [1–4] and subsequent hepatocellular carcinoma [5, 6], and hypoplasia of the thymus [7], are presently known as characteristic morphological abnormalities in LEC rats. Basically, the hepatic lesions of this mutant strain of rat are liver cell degeneration and necrosis, and accumulation of hepatocytes with polyploid huge nuclei [8]. The pathogenesis of hepatic injury has not yet been elucidated, but recently the possibility of the abnormality of methionine metabolism has been suggested from the results of DL-ethionine administration [9]. In examining the response to short-term administration of chemicals or to physical stimulation, the following results have been reported: (1) delay of the hepatic injury by daily intragastric administration of high doses of phenobarbital [10], (2) intensification of hepatic injury by a choline-deficient diet [11] or 0.1% DL-ethionine [9], (3) high susceptibility to initiation by diethylnitrosamine [12], and (4) inhibitory effect of a two-thirds partial hepatectomy on hepatic injury [13].


Partial Hepatectomy Hepatic Injury Hepatic Lesion 49th Annual Meeting Methionine Metabolism 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Sasaki M, Yoshida MC, Kagami K, Takeichi N, Kobayashi H, Dempo K, Mori M (1985) Spontaneous hepatitis in an inbred strain of Long-Evans rats. Rat News Lett 14:4–6.Google Scholar
  2. 2.
    Yoshida MC, Masuda R, Sasaki M, Takeichi N, Kobayashi H, Dempo K, Mori M (1987) New mutation causing hereditary hepatitis in the laboratory rat. J Hered 78:361–365.PubMedGoogle Scholar
  3. 3.
    Takeichi N, Kobayashi H, Yoshida MC, Sasaki M, Dempo K, Mori M (1988) Spontaneous hepatitis in Long-Evans rats. A potential animal model for fulminant hepatitis in man. Acta Pathol Jpn 38:1369–1375.PubMedGoogle Scholar
  4. 4.
    Matsumoto K, Ono E, Izumi K, Otsuka H, Yoshida MC, Sasaki M, Takeichi N, Kobayashi H (1987) Expression of new esterases and pathologic profiles in LEC rats with spontaneous fulminant hepatitis. Transplant Proc 19:3207–3211.Google Scholar
  5. 5.
    Masuda R, Yoshida MC, Sasaki M, Dempo K, Mori M (1988) High susceptibility to hepatocellular carcinoma development in LEC rats with hereditary hepatitis. Jpn J Cancer Res 79:828–835.PubMedCrossRefGoogle Scholar
  6. 6.
    Sawaki M, Enomoto K, Takahashi H, Nakajima Y, Mori M (1990) Phenotype of preneoplastic and neoplastic liver lesions during spontaneous liver carcinogenesis of LEC rats. Carcinogenesis 11:1857–1861.PubMedCrossRefGoogle Scholar
  7. 7.
    Agui T, Oka M, Tamada T, Sakai T, Izumi K, Ishida Y, Himeno K, Matsumoto K (1990) Maturational arrest from CD4+8+ to CD4+8-thymocytes in a mutant strain (LEC) of rat. J Exp Med 172:1615–1624.PubMedCrossRefGoogle Scholar
  8. 8.
    Fujimoto Y, Oyamada M, Hattori A, Takahashi H, Sawaki M, Dempo K, Mori M, Nagao M (1989) Accumulation of abnormally high ploid nuclei in the liver of LEC rats developing spontaneous hepatitis. Jpn J Cancer Res 80:45–50.PubMedCrossRefGoogle Scholar
  9. 9.
    Matsunaga M, Ikeda Y, Sugiyama T, Taniguchi N (1990) Correlation between the methionine metabolism and the expression of the drug metabolizing enzymes in spontaneous hepatitis and hepatoma LEC rats. Proc Jpn Cancer Assoc (49th annual meeting) p 90.Google Scholar
  10. 10.
    Togashi Y, Konaka S, Namieno T, Li Y, Kang J, Takeichi N, Kobayashi H (1990) Effects of phenobarbital on spontaneously developed hepatic injury and carcinoma in LEC rats. Proc Jpn Cancer Assoc (49th annual meeting) p 79.Google Scholar
  11. 11.
    Sugiyama T, Ookawara T, Kinoshita N, Suzuki K, Taniguchi N (1989) Effect of choline deficient diet on the hepatic drug metabolizing enzymes in spontaneous hepatitis and hepatoma LEC rats. Proc Jpn Cancer Assoc (48th annual meeting) p 256.Google Scholar
  12. 12.
    Takahashi H, Enomoto K, Nakajima Y, Mori M (1990) High sensitivity of the LEC rat liver to the carcinogenic effect of diethylnitrosamine. Cancer Lett 51:247–250.PubMedCrossRefGoogle Scholar
  13. 13.
    Takahashi H, Sawada N, Isomura H, Enomoto K, Mori M (1990) Supression of hepatitis in LEC rats by partial hepatectomy. Proc Jpn Cancer Assoc (49th annual meeting) p 66.Google Scholar
  14. 14.
    Dempo K, Chisaka N, Yoshida Y, Kaneko A, Onoe T (1975) Immunofluorescent study on α-fetoprotein-producing cells in the early stage of 3′-methyl-4-dimethylaminoazobenzene carcinogenesis. Cancer Res 35:1282–1287.PubMedGoogle Scholar
  15. 15.
    Shinozuka H, Lombardi B, Sell S, Iammarino, RM (1978) Early histological and functional alterations of ethionine liver carcinogenesis in rats fed a cholinedeficient diet. Cancer Res 38:1092–1098.PubMedGoogle Scholar
  16. 16.
    Keppler D, Lesch R, Reutter W, Decker K (1968) Experimental hepatitis induced by D-galactosamine. Exp Mol Pathol 9:279–290.PubMedCrossRefGoogle Scholar
  17. 17.
    Chisari FV, Filippi P, Buras J, McLachlan A, Popper H, Pinkert CA, Palmiter RD, Brinster RL (1987) Structural and pathological effects of synthesis of hepatitis B virus large envelope Polypeptide in transgenic mice. Proc Natl Acad Sci USA 84:6909–6913.PubMedCrossRefGoogle Scholar
  18. 18.
    Dunsfold HA, Sell S, Chisari FV (1990) Hepatocarcinogenesis due to chronic liver cell injury in hepatitis B virus transgenic mice. Cancer Res 50:3400–3407.Google Scholar
  19. 19.
    Peraino C, Michael Fry RJ, Staffeldt E (1971) Reduction and enhancement by phenobarbital of hepatocarcinogenesis induced in the rat by 2-aeetylaminofluorene. Cancer Res 31:1506–1512.PubMedGoogle Scholar
  20. 20.
    Weisburger JH, Madison RM, Ward JM, Viguera C, Weisburger EK (1975) Modification of diethylnitrosamine liver carcinogenesis with phenobarbital but not with immunosuppression. J Natl Cancer Inst 54:1185–1188.PubMedGoogle Scholar
  21. 21.
    Hosokawa S, Tatematsu M, Aoki T, Nakanowatari J, Igarashi T, Ito N (1989) Modulation of diethylnitrosamine-initiated placental glutathione S-transferase positive preneoplastic and neoplastic lesions by Clofibrate, a hepatic peroxisome proliferator. Carcinogenesis 10:2237–2241.PubMedCrossRefGoogle Scholar
  22. 22.
    Sugiyama T, Takeichi N, Kobayashi M, Yoshida MC, Sasaki M, Taniguchi N (1988) Metabolic predisposition of a novel mutant (LEC rats) to hereditary hepatitis and hepatoma: Alterations of the drug metabolizing enzymes. Carcinogenesis 9:1569–1572.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Tokyo 1991

Authors and Affiliations

  • Keisuke Izumi
  • Hisanori Uehara
  • Hisashi Otsuka
    • 1
  • Kozo Matsumoto
    • 2
  1. 1.Second Department of PathologyUniversity of TokushimaTokushima, 770Japan
  2. 2.Institute for Animal Experimentation, School of MedicineUniversity of TokushimaTokushima, 770Japan

Personalised recommendations